DAWNRAYS PHARMACEUTICAL HLDGSDAWNRAYS PHARMACEUTICAL HLDGSDAWNRAYS PHARMACEUTICAL HLDGS

DAWNRAYS PHARMACEUTICAL HLDGS

No trades
See on Supercharts

2348 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Dawnrays Pharmaceutical Holdings Ltd. operates as an investment holding company, which engages in the development, manufacturing and selling of cephalosporin antibiotics, and various system specific medicines. It operates through the following business segments: Intermediates & Bulk Medicines, and Finished Drugs. The Intermediates & Bulk Medicines segment engages in the manufacturing and selling of intermediates and bulk medicines. The Finished Drugs segment engages in the manufacturing and selling of antibiotics finished drugs and non-antibiotics finished drugs. The company was founded on December 8, 1995 and is headquartered in Hong Kong.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
2348 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company